• Non ci sono risultati.

<Mariarita Brancaccio>

N/A
N/A
Protected

Academic year: 2022

Condividi "<Mariarita Brancaccio> "

Copied!
2
0
0

Testo completo

(1)

Page 1 of 2 Mariarita Brancaccio - Curriculum vitae

<Mariarita Brancaccio>

Born in <Italy> (<Naples>) on 07/04/1988

Tel.: +39 081 5833276 Fax: +39 081 7641355

E-mail: mariarita.brancaccio@szn.it Contatto Skype: brancacciom@hotmail.it Current Position: < Ph. D. student>

For Ph. D. Students:

Director of Studies: <Immacolata Castellano>

Internal Supervisor(s): <Anna Palumbo >

External Supervisor: <Florian Peter Seebeck>

Program: <Open University, XIX cycle>

Affiliation:

Section < Biology and Evolution of Marine Organisms, (BEOM)>, Stazione Zoologica Anton Dohrn, Napoli (Italy)

Education/Training/Experience

Institute and Location Degree / Function

Year Field of Study

Health Biotechnology, Federico II, University of Naples.

Department of Physics, Prof. C. Altucci.

Bachelor degree

2008-2012 Health Biotechnology:

Molecular Pathology, Biochemistry, Cellular and Molecular Biology,

Physics.

Medical Biotechnology, Federico II, University of Naples. Department of

molecular medicine and medical biotechnologies. Prof. L.

Chiariotti, Prof.ssa R.Pero.

Master degree

2012-2014 Medical Biotechnology:

Molecular Biology, Genetics and Synthesis of biomolecules,

Pharmacogenomics and Gene Therapy, Epigenetic.

Department of Molecular Post-graduate July 2014 – Use of animal models for

(2)

Page 2 of 2 Mariarita Brancaccio - Curriculum vitae

Medicine and Medical

biotechnologies , University of Naples, Federico II. Prof. L.

Chiariotti, Prof.ssa R.Pero

training December 2014

Study of neuropsychiatric diseases.

University of Sannio, (Benevento, Italy).

Enrollment at the National Biological Order.

February 2015

Biology

IRBM SCIENCE PARK.

CNR (National Research Center), Via Pietro Castellino 111, Naples, Italy. Laboratory of Molecular Biology, Dr. F.

Varrone.

Junior Researcher

2015-2017 Use of cell culture and animal models for the study of molecules that can be used in regenerative medicine.

Publications

Journal Papers

Angrisano T, Pero R, Brancaccio M, Coretti L, Florio E, Pezone A, Calabrò V, Falco G, Keller S,Lembo F, Avvedimento VE, Chiariotti L. Cyclical DNA Methylation and Histone Changes Are Induced by LPS to Activate COX-2 in Human Intestinal Epithelial Cells. PLoS One. 2016 Jun 2;11(6):e0156671. doi: 10.1371/journal.pone.0156671. eCollection 2016.

Brancaccio M, Ragozzino E, Salerno M, Wanderlingh LG, Patriarca EJ, Summa V, Altamura S†, Varrone F. 6-Bromoindirubin-3’- oxime (BIO) intercepts GSK3 signaling to promote and

enhance skeletal muscle differentiation by miR-206 modulation (under review).

Book chapters

Brancaccio M, Lembo F, Chiariotti L, Pero R and Angrisano T. LPS infection of intestinal epithelial cells induces expression of COX-2 trough epigenetic mechanisms. Abstract Book ,42° congress SIM (Società Italiana Microbiologi), Torino 28 Settembre - 1 Ottobre 2014;

pp.180.

Coretti L, Liguori E, Santarpia L, Scala G, Florio E, Brancaccio M, Iervolino C, Pero R, Donnarumma G, Lembo F, Chiariotti L. Metagenomic analysis of fecal microbiota in patients with different conditions of malnutrition. Abstract Book, 42° congress SIM (Società Italiana Microbiologi), Torino 28 Settembre - 1 Ottobre 2014; pp.193.

Riferimenti

Documenti correlati

On the basis of new insights into the genetic basis of different types of he- reditary neuropathies, several animal models have been generated using transgenic and gene

Wirtz S, Finotto S, Kanzler S, Lohse AW, Blessing M, Lehr HA, Galle PR, Neurath MF (1999) Cutting Edge: Chronic intestinal inflammation in STAT-4 transgenic mice: characterization

Our animal model reflecting the component of persistent allergic inflammation of small airways in association with increased airway reactivity and airflow limitation

Similar to Christi and colleagues’ approach to modeling accelerated amyloid pathology in transgenic mice (35), Lim and coworkers generated transgenic mice expressing 4R2N human

Ideally, animal models used to study process or outcome vari- ables would be amenable to modeling all aspects of the disease including the ischemia of the arrest itself (down time),

Antiangiogenic and antitumor activity of anti- epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense

Models of type 1 diabetes should have low insulin levels, although models of type 2 diabetes should have normal or slightly elevated plasma insulin. Both diabetes models should

Usage of antimicrobials as growth promoters belonging to the same antimicrobial group as the therapeutic-used antimicrobials will diminish the potential of the therapeutic